{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T18:24:36Z","timestamp":1750098276906},"reference-count":24,"publisher":"Japanese Society of Internal Medicine","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2014]]},"DOI":"10.2169\/internalmedicine.53.1735","type":"journal-article","created":{"date-parts":[[2014,5,31]],"date-time":"2014-05-31T23:22:11Z","timestamp":1401578531000},"page":"1177-1181","source":"Crossref","is-referenced-by-count":7,"title":["Rheumatoid Arthritis\/Methotrexate-associated Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type"],"prefix":"10.2169","volume":"53","author":[{"given":"Yosuke","family":"Matsumoto","sequence":"first","affiliation":[{"name":"Department of Molecular Hematology and Oncology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kawaramachi Hirokoji, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Horiike","sequence":"additional","affiliation":[{"name":"Department of Molecular Hematology and Oncology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kawaramachi Hirokoji, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saori","family":"Maekawa","sequence":"additional","affiliation":[{"name":"Department of Molecular Hematology and Oncology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kawaramachi Hirokoji, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Isohisa","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kawaramachi Hirokoji, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsumi","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Molecular Hematology and Oncology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kawaramachi Hirokoji, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Chinen","sequence":"additional","affiliation":[{"name":"Department of Molecular Hematology and Oncology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kawaramachi Hirokoji, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuko","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Department of Molecular Hematology and Oncology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kawaramachi Hirokoji, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miki","family":"Kiyota","sequence":"additional","affiliation":[{"name":"Department of Molecular Hematology and Oncology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kawaramachi Hirokoji, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisao","family":"Nagoshi","sequence":"additional","affiliation":[{"name":"Department of Molecular Hematology and Oncology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kawaramachi Hirokoji, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Mizutani","sequence":"additional","affiliation":[{"name":"Department of Molecular Hematology and Oncology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kawaramachi Hirokoji, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Shimura","sequence":"additional","affiliation":[{"name":"Department of Molecular Hematology and Oncology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kawaramachi Hirokoji, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mio","family":"Sugitani","sequence":"additional","affiliation":[{"name":"Department of Molecular Hematology and Oncology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kawaramachi Hirokoji, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Molecular Hematology and Oncology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kawaramachi Hirokoji, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriaki","family":"Nakai","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kawaramachi Hirokoji, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junya","family":"Kuroda","sequence":"additional","affiliation":[{"name":"Department of Molecular Hematology and Oncology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kawaramachi Hirokoji, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Taniwaki","sequence":"additional","affiliation":[{"name":"Department of Molecular Hematology and Oncology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kawaramachi Hirokoji, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC, Lyon, 2008."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 105: 3768-3785, 2005.","DOI":"10.1182\/blood-2004-09-3502"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Mellemkjaer L, Linet MS, Gridley G, Frisch M, M&oslash;ller H, Olsen JH. Rheumatoid arthritis and cancer risk. Eur J Cancer 32A: 1753-1757, 1996.","DOI":"10.1016\/0959-8049(96)00210-9"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Thomas E, Brewster DH, Black RJ, Macfarlane GJ. Risk of malignancy among patients with rheumatic conditions. Int J Cancer 88: 497-502, 2000.","DOI":"10.1002\/1097-0215(20001101)88:3<497::AID-IJC27>3.0.CO;2-J"},{"key":"5","unstructured":"5. Wolfe F, Michaud K. Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients. Arthritis Rheum 50: 1740-1751, 2004."},{"key":"6","unstructured":"6. Askling J, Fored CM, Baecklund E, et al. Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists. Ann Rheum Dis 64: 1414-1420, 2005."},{"key":"7","unstructured":"7. Mariette X, Cazals-Hatem D, Warszawki J, Liote F, Balandraud N, Sibilia J; Investigators of the Club Rhumatismes et Inflammation. Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France. Blood 99: 3909-3915, 2002."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Baecklund E, Iliadou A, Askling J, et al. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum 54: 692-701, 2006.","DOI":"10.1002\/art.21675"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Rustin GJ, Rustin F, Dent J, Booth M, Salt S, Bagshawe KD. No increase in second tumors after cytotoxic chemotherapy for gestational trophoblastic tumors. N Engl J Med 308: 473-476, 1983.","DOI":"10.1056\/NEJM198303033080901"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Nyfors A, Jensen H. Frequency of malignant neoplasms in 248 long-term methotrexate-treated psoriatics. A preliminary study. Dermatologica 167: 260-261, 1983.","DOI":"10.1159\/000249793"},{"key":"11","unstructured":"11. Kamel OW, van de Rijn M, Weiss LM, et al. Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med 328: 1317-1321, 1993."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Salloum E, Cooper DL, Howe G, et al. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol 14: 1943-1949, 1996.","DOI":"10.1200\/JCO.1996.14.6.1943"},{"key":"13","unstructured":"13. Baecklund E, Sundstr&ouml;m C, Ekbom A, et al. Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma. Arthritis Rheum 48: 1543-1550, 2003."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA 140: 659-662, 1949.","DOI":"10.1001\/jama.1949.02900430001001"},{"key":"15","unstructured":"15. Senff NJ, Hoefnagel JJ, Jansen PM, et al. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers. J Clin Oncol 25: 1581-1587, 2007."},{"key":"16","unstructured":"16. Kodama K, Massone C, Chott A, Metze D, Kerl H, Cerroni L. Primary cutaneous large B-cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patients. Blood 106: 2491-2497, 2005."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Vermeer MH, Geelen FA, van Haselen CW, et al. Primary cutaneous large B-cell lymphomas of the legs. A distinct type of cutaneous B-cell lymphoma with an intermediate prognosis. Dutch Cutaneous Lymphoma Working Group. Arch Dermatol 132: 1304-1308, 1996.","DOI":"10.1001\/archderm.132.11.1304"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Niitsu N, Okamoto M, Nakamine H, Hirano M. Clinicopathologic correlations of diffuse large B-cell lymphoma in rheumatoid arthritis patients treated with methotrexate. Cancer Sci 101: 1309-1313, 2010.","DOI":"10.1111\/j.1349-7006.2010.01517.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103: 275-282, 2004.","DOI":"10.1182\/blood-2003-05-1545"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Hallermann C, Kaune KM, Gesk S, et al. Molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6, and MALT1 gene loci in primary cutaneous B-cell lymphomas. J Invest Dermatol 123: 213-219, 2004.","DOI":"10.1111\/j.0022-202X.2004.22720.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Dijkman R, Tensen CP, Jordanova ES, et al. Array-based comparative genomic hybridization analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B-cell lymphoma. J Clin Oncol 24: 296-305, 2006.","DOI":"10.1200\/JCO.2005.02.0842"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Gaitonde S, Kavuri S, Alagiozian-Angelova V, Peace D, Worobec S. EBV positivity in primary cutaneous large B-cell lymphoma with immunophenotypic features of leg type: an isolated incident or something more significant? Acta Oncol 47: 461-464, 2008.","DOI":"10.1080\/02841860701621241"},{"key":"23","unstructured":"23. Dawson TM, Starkebaum G, Wood BL, Willkens RF, Gown AM. Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sj&ouml;gren's syndrome: case series. J Rheumatol 28: 47-53, 2001."},{"key":"24","unstructured":"24. Hoshida Y, Xu JX, Fujita S, et al. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol 34: 322-331, 2007."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/11\/53_53.1735\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:51:14Z","timestamp":1621446674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/11\/53_53.1735\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.53.1735","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}